Bausch's Thermage reaches five million skin treatments

Mr. Thomas Appio reports BAUSCH HEALTH'S AESTHETIC BUSINESS, SOLTA MEDICAL, SURPASSES MILESTONE OF 5 MILLION SKIN TIGHTENING TREATMENTS WITH THERMAGE NON-SURGICAL SYSTEM Bausch Health Companies Inc's proven Thermage technology has been used to perform more than five million skin tightening and smoothing treatments. Thermage utilizes monopolar radiofrequency energy that can safely heat layers of skin and stimulate collagen production, naturally. With every Thermage treatment, patients embrace a non-invasive path to visibly smoother, tighter skin -- rooted in proven technology, backed by patented innovation and trusted around the globe. Patients rely on Thermage for their yearly facial, body and eye treatments. It is the only non-invasive technology indicated for use on the upper and lower eyelids for wrinkles. "Thermage has surpassed five million tips used worldwide, a testament to the trusted science behind every treatment," said Jiny Kim, senior vice-president, Solta Medical, Bausch Health. "We want to thank every patient, consumer, health care provider and employee for being part of a global story that keeps growing. Thermage is dedicated to helping individuals enhance their natural beauty through non-invasive skin tightening solutions. We will continue to advance our technology by investing in research and development, as well as gathering clinical evidence. We are just only getting started." "We are proud to celebrate this incredible milestone achieved by Thermage technology," said Thomas J. Appio, chief executive officer, Bausch Health. "This accomplishment reflects our commitment to innovative solutions in aesthetics, and demonstrates the trust that patients and providers place in our products globally." About Bausch Health Companies Inc. Bausch Health is a global, diversified pharmaceutical company enriching lives through its relentless drive to deliver better health care outcomes. It develops, manufactures and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through its controlling interest in Bausch + Lomb. Its ambition is to be a globally integrated health care company, trusted and valued by patients, HCPs, employees and investors. Its aesthetic business, Solta Medical, is a global leader in the aesthetics market, whose vision is to develop and support trusted aesthetic brands that provide value to its customers and patients. We seek Safe Harbor.